A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-31 in Healthy Infants
Clinical trial NCT06720038 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06720038
- Sponsor
- Vaxcyte, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2027-12-01
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.